Aristopharma Ltd. has launched Ferijet which ensures faster recovery from anemia in adults.

Ferijet (Ferric carboxymaltose) is a colloidal iron (III) hydroxide in complex with Carboxymaltose, a Carbohydrate polymer that releases iron. It is an intravenous iron therapy used to treat iron deficiency anemia in adults. It offers rapid correction of anemia, minimal infusion sessions, higher patient compliance & lower risk of hypersensitivity